| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000016584 |
| Receipt No. | R000019240 |
| Official scientific title of the study | Combination of revascularization surgery and double filtration plasmapheresis with thermo-recirculation (DF Thermo) for the treatment of peripheral arterial disease (ASO) |
| Date of disclosure of the study information | 2015/02/20 |
| Last modified on | 2017/12/23 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Combination of revascularization surgery and double filtration plasmapheresis with thermo-recirculation (DF Thermo) for the treatment of peripheral arterial disease (ASO) | |
| Title of the study (Brief title) | Combination of revascularization surgery and double filtration plasmapheresis with thermo-recirculation (DF Thermo) for the treatment of peripheral arterial disease (ASO) | |
| Region |
|
|
| Condition | ||
| Condition | Peripheral arterial disease with wound and/or ulcer in the lower limb | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy of DF Thermo therapy in the severe ischemic limb ASO patients who underwent bypass revascularization surgery, and with wound and/or ulcer in the lower limb. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Rate of diminishment of wound and/or ulcer by DF thermo therapy |
| Key secondary outcomes | SPP, ABI, ultrasonography of lower limb, VEGF, fibrinogen, IgM, LDL-cholesterol, HDL-cholesterol, total cholesterol, DESIGN-R, Vascu QOL |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | DF Thermo group (Patients underwent DF Thermo therapy)
Study period; 35 weeks at the maximum |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who fulfill all of the following conditions are included.
1) Age is over 20 years and less than 86 years, regardless of sex 2) Diagnosed as ASO with Fontaine Grade IV 3) With wound and/or ulcer in the lower limb and underwent bypass revascularization surgery 4) Patients who can give written informed consent by themselves or by their surrogates, understanding the objective and content of the study |
|||
| Key exclusion criteria | Patients who fulfill any of the following conditions are excluded.
1) Pregnancy, breast-feeding, with possibility of pregnancy, or who wish to become pregnant during the study period 2) Patients who are considered as inadequate by the physician in charge |
|||
| Target sample size | 12 | |||
| Research contact person | |
| Name of lead principal investigator | Shinji Togashi |
| Organization | Shonai Amarume Hospital |
| Division name | Plastic and reconstructive surgery |
| Address | 1-1-1 Shoyo, Shonai-town, Hogashitagawa, Yamagata |
| TEL | 0234-43-3434 |
| stoga@amarume-hp.jp | |
| Public contact | |
| Name of contact person | Shinji Togashi |
| Organization | Shonai Amarume Hospital |
| Division name | Plastic and reconstructive surgery |
| Address | 1-1-1 Shoyo, Shonai-town, Hogashitagawa, Yamagata |
| TEL | 0234-43-3434 |
| Homepage URL | |
| stoga@amarume-hp.jp | |
| Sponsor | |
| Institute | Shonai Amarume Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kawasumi Laboratories, Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019240 |